Study Detail

nCoV: Developing CoV-bnMABs for therapy of highly pathogenic coronaviruses including SARS-CoV-2

nCoV: Developing CoV-bnMABs for therapy of highly pathogenic coronaviruses including SARS-CoV-2

Status: Possible pre-clinical study

Type: Pre-clinical

Funder: NIHR/UKRI

Sponsor: not available

CI: Professor Xiao-Ning Xu

IRAS-Number: Pre-clinical

CPMS-ID: not available

Approval Date: 11 March 2020

Back to listing